Calendar Perspective Therapeutics, Inc.

Equities

CATX

US46489V1044

Market Closed - Nyse 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
1.19 USD -0.83% Intraday chart for Perspective Therapeutics, Inc. -11.19% +196.02%

Chart calendar Perspective Therapeutics, Inc.

4b408cebbdcc5062d138b351a94af.XO7WJtrm6cZxmxrbuY_ajZY-R6EuQBfDkBkqGZ5K4JA.MZm8XJuT24U96WqYy_m5uthWftRUd1ilwE95cdQvjucvvINsoMuYnBzccQ~0173067d71c8fa0fdaf56adefd67c254

Upcoming events on Perspective Therapeutics, Inc.

2024-05-13 Q1 2024 Earnings Release (Projected)
2024-08-08 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)

Past events on Perspective Therapeutics, Inc.

2024-03-28 07:30 am Q4 2023 Earnings Release
2024-03-18 10:00 am Analyst Day
2024-03-01 02:30 pm B. Riley Securities Radiopharma Day - Panel
2024-03-01 01:45 pm B. Riley Securities Radiopharma Day - Panel
2024-03-01 10:00 am B. Riley Securities Radiopharma Day - Panel
2024-02-28 11:00 am Investor Meeting
2024-02-14 11:20 am Oppenheimer Healthcare Life Sciences Conference
2024-01-11 03:00 pm JPMorgan Healthcare Conference
2024-01-08 01:30 pm Biotech Showcase
2024-01-07 BIO Partnering JPM Conference
2024-01-07 05:30 pm BFC Global HealthCare BD & Investment Conference
2024-01-07 12:15 pm BFC Global HealthCare BD & Investment Conference - Panel
2023-11-14 04:25 pm Q3 2023 Earnings Release
2023-10-05 Annual General Meeting
2023-10-03 North American Neuroendocrine Tumor Society Symposium - Phase 1/2 Trial of Pb-212-VMT
2023-10-03 North American Neuroendocrine Tumor Society Symposium - Phase 1 Trial of Pb-212-VMT
2023-09-30 American Society for Radiation Oncology Conference
2023-09-12 03:45 am European Association of Nuclear Medicine Congress - Abstract Number: OP-673
2023-09-10 09:00 am European Association of Nuclear Medicine Congress - Abstract Number: OP-144
2023-09-07 05:00 am World Molecular Imaging Congress - Abstract No : 131

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
5,92
5,87
0.97%
7,31
7,41
-1.35%
9,68
10,1
-4.08%
10,1
10,0
0.2%
3,55


1,43
8,46
-83.04%
EBITDA
Million USD
Released
Forecast
Spread
-6,60
-5,60
-17.84%
-5,07
-5,10
0.63%
-2,87
-3,10
7.45%
-2,87
-2,80
-2.64%
0,00


0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-6,73
-5,99
-12.29%
-5,25
-5,62
6.45%
-3,55
-3,40
-4.28%
-3,45
-3,29
-4.62%
0,00


-40,9
-43,4
5.6%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,70
-5,97
-12.27%
-5,14
-5,53
6.92%
-3,45
-3,39
-1.77%
-3,39
-3,30
-2.64%
0,00


-40,1
-43,0
6.64%
Net income
Million USD
Released
Forecast
Spread
-6,71
-5,97
-12.39%
-5,16
-5,53
6.72%
-3,46
-3,39
-2.1%
-3,39
-3,25
-4.3%
0,00


-46,5
-37,7
-23.33%
EPS
USD
Released
Forecast
Spread
-0,12
-0,11
-12.5%
-0,08
-0,09
5.88%
-0,05
-0,05
-11.11%
-0,03
-0,03
-12.49%
-0,05


-0,17
-0,14
-21.43%
Announcement Date25/09/1824/09/1917/09/2021/09/2101/05/2328/03/24

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
2,60
2,41
7.68%
2,71
2,70
0.37%
2,06


2,09
2,61
-20%
1,91
2,20
-13.23%
-4,90
2,12
-331.06%

1,98


0,00


0,00


0,12

EBITDA
Million USD
Released
Forecast
Spread
-0,72
-0,70
-3%
-0,92
-0,80
-14.5%
























EBIT
Million USD
Released
Forecast
Spread
-0,77
-0,80
4.31%
-1,09
-0,91
-20.2%



-11,4
-7,66
-48.56%
-10,5
-10,3
-2.57%
-7,81
-10,2
23.79%












Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-0,75
-0,80
6.88%
-1,06
-0,90
-17.89%



-11,1
-7,65
-45.21%
-10,4
-10,3
-0.92%
-7,77
-10,7
27.11%

-10,9


-10,6


-10,8


-11,1

Net income
Million USD
Released
Forecast
Spread
-0,75
-0,80
6.58%
-1,06
-0,91
-16.94%



-11,1
-7,65
-45.16%
-10,4
-10,3
-0.89%
-24,7
-10,7
-131.35%

-10,9


-10,6


-10,8


-11,1

EPS
USD
Released
Forecast
Spread
-0,01
-0,01
0%
-0,01
-0,01
0%
0,00


-0,04
-0,03
-33.33%
-0,04
-0,04
0%
-0,09
-0,04
-125%

-0,04


-0,03


-0,03


-0,03

Announcement Date13/05/2121/09/2115/05/2311/08/2314/11/2328/03/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Perspective Therapeutics, Inc. - Nyse
  4. Calendar Perspective Therapeutics, Inc.